However, concurrent administration of α7 nicotinic receptor antagonist α-BGT (1 μg/kg/d) with DMXBA eliminated the effects of DMXBA on depression-like behaviors, confirming the role of α7nAChR in mediating the effects of DMXBA. This evidence concerns the gene CHRNA7 and depressive symptom measurement.